Conditional survival among patients with carcinoma of the lung

Chest

Volumn 116, Issue 3, 1999, Pages 697-703

  Merrill, Ray M ^a,b   Henson, Donald Earl ^c   Barnes, Michael ^a  

^a BRIGHAM YOUNG UNIVERSITY   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Annual hazards; Conditional survival; Lung neoplasms; Observed survival; Outcome

Indexed keywords

ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; HUMAN; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; ONSET AGE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT;

EID: 0032842754     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.116.3.697     Document Type: Article

References (16)

1. 1 Henson DE, Ries LA. On the estimation of survival. Semin Surg Oncol 1994; 10:1-5
2. 2 Henson DE, Ries LA, Carriaga MT. Conditional survival of 56,268 patients with breast cancer. Cancer 1995; 76:237-242
3. 3 Merrill RM, Henson DE, Ries LA. Conditional survival estimates in 34,963 patients with invasive carcinoma of the colon. Dis Colon Rectum 1998; 41:1097-1106
4. 4 Ries LA, Kosary CL, Hankey BF, et al, eds. SEER cancer statistics review, 1973-1994. Bethesda, MD: National Cancer Institute, National Institutes of Health, 1997; Publication No. 97-2789
5. 5 Travis WD, Travis LB, Devesa SS. Lung cancer. Cancer 1995; 75:191-202
6. 6 Morabia A, Wynder EL. Cigarette smoking and lung cancer cell types. Cancer 1991; 68:2074-2078
7. 7 Ries, LA. Influence of extent of disease, histology, and demographic factors on lung cancer survival in the SEER population-based data. Semin Surg Oncol 1994; 10:21-30
8. 8 International classification of diseases for oncology. 2nd ed. Geneva, Switzerland: World Health Organization, 1990
9. 9 SEER program: comparative staging guide for cancer. Vernon 1.1. Bethesda, MD: National Institutes of Health, 1993; Publication No. 93-3640
10. 10 Ederer F, Axtell LM, Cutler SJ. The relative survival rate: a statistical methodology. Natl Cancer Inst Monog 1961; 6:101-121
11. 11 National Cancer Institute. SEER cancer incidence public-use database 1973-1995. Rockville, MD: National Cancer Institute, 1998
12. 12 Reducing the health consequences of smoking: 25 years of progress; a report of the Surgeon General. Washington, DC: US Department of Health and Human Services, 1989; DHHS Publication No. (CDC) 89-8411
13. 13 Doll R, Peto R. The causes of cancer in quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981; 66:1191-1308
14. 14 McDuffie HH, Klaassen DJ, Dosman JA. Determinants of cell type in patients with cancer of the lungs. Chest 1990; 98:1187-1193
15. 15 Birchard K. New treatments reported for lung cancer. Lancet 1997; 350:568
16. 16 Zou Y, Zong G, Ling YH, et al. Effective treatment of early endobroncbial cancer with regional administration of liposome-p53 complexes. J Natl Cancer Inst 1998; 90:1130-1137